Royal Philips is increasing the production of certain critical care products and solutions to help diagnose and treat patients with the new coronavirus disease (COVID-19).

The most needed products are patient vital signs monitors and portable ventilators and medical consumables for non-invasive and invasive ventilation to treat a broad range of respiratory conditions. Other Philips products and solutions to help address the preparedness, response and recovery needs of COVID-19 include a range of diagnostic imaging systems (CT, mobile diagnostic X-ray, and ultrasound) to help diagnose and assess respiratory conditions, as well as hospital telehealth solutions to centrally monitor and manage patients in the intensive care unit (Philips eICU program), and telehealth solutions to connect caregivers and patients at home.

For example, Philips is ramping up the production of hospital ventilators and plans to double production within the next eight weeks and achieve a four-fold increase by the third quarter of 2020. The company is mobilizing its global supplier network to step up support and production in this extraordinary situation. Philips has a global manufacturing footprint with final assembly sites in North America, Europe and Asia, and, equally important, a global network of certified materials and component suppliers.

Philips’ efforts to increase the production include:

• Hiring additional manufacturing employees and shifting current employees to support increased demand immediately;
• Adding manufacturing lines and increasing the number of shifts to 24/7 shifts;
• Working closely with Philips’ suppliers to secure materials supply to feed the increased production at our manufacturing sites;
• Leveraging Philips’ innovation capabilities to re-purpose adjacent product ranges to address the increased demand;
• Engaging with third party contract manufacturers.